R. Plachý

Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panel.

M. Jarošová, Z. Pikalová, K. Indrák, 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Gain of chromosome 2p in chronic lymphocytic leukemia: significant heterogeneity and a new recurrent dicentric rearrangement

V. Divoky, M. Jarošová, Z. Pikalová, 2010, Leukemia & lymphoma.

Molecular characterization of the rare translocation t(3;10)(q26;q21) in an acute myeloid leukemia patient

K. Kreuzer, A. Rothe, M. Othman, 2014, Molecular Cytogenetics.

McRAPD as a new approach to rapid and accurate identification of pathogenic yeasts.

Petr Hamal, P. Hamal, V. Raclavský, 2005, Journal of microbiological methods.

A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.

M. Karas, R. Cmejla, L. Smolej, 2011, Leukemia research.

Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation.

M. Jarošová, K. Indrák, E. Faber, 2010, Leukemia research.

A method to identify new molecular markers for assessing minimal residual disease in acute leukemia patients.

T. Liehr, M. Karas, R. Cmejla, 2013, Leukemia research.

Precursor T-Lymphoblastic Lymphoma as a Secondary Malignancy in a Young Patient after Successful Treatment of Acute Promyelocytic Leukemia

M. Jarošová, Z. Pikalová, K. Indrák, 2009, Oncology Research and Treatment.